Kevin Volpp's work has earned him the 2015 Matilda White Riley Award, issued by the National Institutes of…
Scott Halpern has been elected to membership in the American Society For Clinical Investigation (ASCI), a century-old medical honors society that supports the…
Justin Bekelman, MD, Assistant Professor of Radiation Oncology at the medical school and CHIBE affiliated faculty member, will receive $11.9 million for a five-year…
At the Translational Science 2015 annual meeting, The Association for Clinical and Translational Science and The American Federation for Medication Research…
Directors: Karen Glanz, PhD, MPH; Kevin Volpp, MD, PhD
A five-year, $4,350,000 grant from the Centers for Disease Control and Prevention has established a Prevention Research Center (PRC) at the University of Pennsylvania. The PRC, one of 26 in the nation, will conduct innovative public health and disease management research aimed at preventing chronic disease and reducing health disparities in Southeastern Pennsylvania. This will be the first PRC in Philadelphia.
Among other initiatives, the PRC will conduct a workplace weight loss study to evaluate environmental change strategies and incentives for decreasing obesity and preventing cardiovascular disease in employees of the City of Philadelphia, Independence Blue Cross, and the Southeastern Pennsylvania Transportation Authority (SEPTA).
Principal Investigators: Peter Reese, Kevin Volpp
Financial incentives have been shown to be effective at improving patient health behaviors including medication adherence in a wide variety of contexts. The delivery of such incentives has been enhanced by the recent development of new wireless technologies that facilitate the measurement of daily medication adherence and the provision of incentives in an automated fashion. However, the relative effectiveness of incentives based on process (e.g. statin adherence) versus outcome (e.g. improvements in LDL cholesterol) is unknown.This is a randomized controlled trial to evaluate the relative effectiveness and cost-effectiveness of improving cholesterol levels among participants who are at high risk of CVD and who have elevated LDL cholesterol levels by testing process versus outcomes financial incentives.
Funder: National Heart, Lung and Blood Institute
Principal Investigator: Peter Reese
This Roybal pilot is a randomized, controlled trial to compare the effects of four interventions on the rate of organ donor registration by members of the general public who visit the DMV website for business unrelated to organ donor registration.
Funded by: Roybal P30 Pilot
Principal Investigators: Judith Long, Ilona Lorincz
This project will develop and pilot a three month randomized control trial (RCT) of a Motivational Interviewing (MI)‐informed SMS intervention tailored to patient level of activation in a population of patients with poorly controlled type II diabetes. The pilot will inform the development of a larger RCT, powered to detect a change in glycemic control.
Funded By: Roybal P30 Pilot